Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03978689
Title A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Cue Biopharma
Indications

head and neck squamous cell carcinoma

Therapies

CUE-101 + Pembrolizumab

CUE-101

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST